Director-General of NAFDAC, Prof. Mojisola Adeyeye, delivered a presentation at the Invest Nigeria Conference & Expo 4.0, hosted by the Lagos Chamber of Commerce and Industry (LCCI) at Eko Hotels and Suites, Victoria Island, Lagos.
Speaking on _”The Roles of NAFDAC with Regards to Investments in Nigeria,”_ Prof. Adeyeye outlined the Agency’s regulatory reforms and the measurable progress recorded in stimulating local manufacturing and attracting investment in Nigeria’s health products sector.
Prof. Adeyeye highlighted NAFDAC’s sustained Maturity Level 3 (ML3) status, the highest benchmarking rating in Africa, as a cornerstone of investor confidence, alongside full ICH membership attained in November 2025.
She detailed the impact of the Agency’s 5+5 Policy and Ceiling List: contract manufacturing partnerships grew from 10 companies in 2019 to 87 in 2025; 176 facility layout reviews have been approved as of June 2026; and over 70% of products under both directives are now locally manufactured.
She also noted a rise in foreign direct investment, with joint ventures and technology transfers involving firms from India, South Korea, and Turkey, and referenced the Presidential Executive Order on Local Production as reinforcing NAFDAC’s regulatory framework.
Prof. Adeyeye called on stakeholders to sustain collaboration with the Agency, and reaffirmed NAFDAC’s commitment to a market-friendly regulatory environment that protects public health while enabling investment and advancing Nigeria’s domestic production capacity.